Understanding mild cognitive impairment and Alzheimer's disease risk factors across different countries
Mild Cognitive Impairment and Alzheimer's Disease and Related Dementias: Cross-national longitudinal prognosis and risk factors
This study is looking to find out how to spot people who might be at risk for Alzheimer's and related memory issues early on, especially those with mild cognitive impairment, so we can better understand how it develops and help create ways to prevent it, particularly in different communities around the world.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10940117 on NIH RePORTER |
What this research studies
This research investigates the early identification of individuals at high risk for Alzheimer's disease and related dementias (ADRD), particularly focusing on mild cognitive impairment (MCI). It aims to improve the measurement of MCI and understand its progression in diverse populations, especially in low- and middle-income countries. By examining various social, economic, and cultural factors, the study seeks to identify key risk factors and develop better prevention strategies. Patients may be assessed through cognitive tests and evaluations to determine their risk levels.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults over 21 years old who may be experiencing mild cognitive impairment or are at risk for Alzheimer's disease.
Not a fit: Patients who do not have any cognitive impairment or are not at risk for Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved early detection and intervention strategies for Alzheimer's disease, potentially delaying its onset and progression.
How similar studies have performed: Previous research has shown success in identifying risk factors for Alzheimer's disease, but this study aims to expand understanding in underrepresented populations, making it a novel approach.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Arce, Miguel — Columbia University Health Sciences
- Study coordinator: Arce, Miguel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.